🇺🇸 LNTH — Lantheus Holdings, Inc.

Salud Mantener
← Volver

Precio actual

101,14 USD

Máx. histórico

123,62

846 días

Caída desde máximo

-18,18%

Rango 52 semanas

50,16 – 111,86

Variación hoy

+0,34%

Cierre anterior

100,80

Rango de hoy

100,88 – 101,27

Volumen hoy

1.095.277

Peor caída histórica

-78,62%

17/08/2015 → 08/02/2016

Recuperado en 202 días

Volatilidad anualizada ⓘ

63,43%

Información
Nombre completo
Lantheus Holdings, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
1.193
PER ⓘ
24,37 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
106,99 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 3 horas
Sobre la empresa

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. It also provides Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; PYLARIFY AI, an medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer; and flurpiridaz used to assess blood flow to the heart. In addition, it develops PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy to patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent for Tau tangles in Alzheimer's disease; LNTH-2401, a novel radiodiagnostic targeting the gastrin-releasing peptide receptor; LNTH-2402; LNTH-2403; LNTH-2404; LNTH-250; LNTH-2515; and LNTH-1363S, an fibroblast activation protein, alpha, copper-64 labeled PET imaging agent. It has collaboration agreements with GE Healthcare; Curium Pharma; POINT; Regeneron; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/01/2020 18,57 19,18 18,32 18,87 +1,89% 4,63% 921.500
14/01/2020 18,08 18,59 17,80 18,52 +2,60% 4,37% 687.300
13/01/2020 19,15 19,23 18,00 18,05 -5,84% 6,40% 374.700
10/01/2020 18,88 19,21 18,59 19,17 +2,08% 3,28% 445.800
09/01/2020 20,22 20,22 18,74 18,78 -6,33% 7,32% 481.700
08/01/2020 19,30 20,16 19,30 20,05 +3,83% 4,46% 515.300
07/01/2020 19,37 19,70 19,22 19,31 -0,77% 2,45% 251.200
06/01/2020 19,11 19,55 18,62 19,46 +1,41% 4,84% 396.000
03/01/2020 18,90 19,45 18,70 19,19 -0,31% 3,97% 380.500
02/01/2020 20,67 20,67 19,15 19,25 -6,14% 7,35% 343.900
31/12/2019 20,18 20,68 20,04 20,51 +1,23% 3,15% 238.600
30/12/2019 20,37 20,77 20,20 20,26 -0,05% 2,80% 349.900
27/12/2019 20,66 20,68 20,19 20,27 -1,41% 2,37% 247.900
26/12/2019 20,72 20,93 20,40 20,56 -1,44% 2,58% 219.900
24/12/2019 20,60 20,96 20,37 20,86 +1,21% 2,86% 98.100
23/12/2019 20,83 21,00 19,50 20,61 -0,48% 7,20% 437.100
20/12/2019 21,10 21,10 20,51 20,71 -1,62% 2,80% 702.600
19/12/2019 21,29 21,34 20,81 21,05 -1,47% 2,49% 277.600
18/12/2019 20,70 21,42 20,60 21,37 +2,91% 3,96% 281.000
17/12/2019 20,78 20,78 20,22 20,76 +0,78% 2,72% 297.600
16/12/2019 20,52 21,08 20,40 20,60 +1,68% 3,31% 487.400
13/12/2019 20,56 20,70 20,08 20,26 -1,79% 3,02% 306.100
12/12/2019 20,41 21,07 20,27 20,63 +0,78% 3,92% 572.000
11/12/2019 20,22 20,71 20,06 20,47 +1,59% 3,21% 338.800
10/12/2019 20,16 20,43 20,06 20,15 -0,42% 1,84% 310.800
09/12/2019 20,40 20,45 19,93 20,24 -1,00% 2,55% 311.300
06/12/2019 20,60 20,89 20,38 20,44 -0,34% 2,48% 382.300
05/12/2019 20,28 20,75 20,08 20,51 +1,53% 3,30% 686.100
04/12/2019 20,31 20,49 20,09 20,20 +0,25% 1,97% 516.600
03/12/2019 20,15 20,55 19,88 20,15 -0,57% 3,35% 416.200